StockData
Summit Therapeutics Inc. logo

Summit Therapeutics Inc. (SMMT) stock

SMMTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$10.50−0.17 (-1.59%)

Close on Nov 18, 2026Market cap $8.38BP/E –Yield –

Summit Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Summit Therapeutics's market cap was $13.20B on Nov 11, 2026, against $13.32B a year earlier. Over the last 5 years it ranged from $98.12M to $19.56B, with a median of $6.10B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$13.20B+1.4%
2025Dec 31, 2025$13.02B-1.0%
2024Dec 31, 2024$13.15B+622.2%
2023Dec 29, 2023$1.82B+112.9%
2022Dec 30, 2022$855.61M+225.8%
2021Dec 31, 2021$262.62M+224.3%
2020Dec 31, 2020$80.97M+193.7%
2019Dec 31, 2019$27.57M+83.2%
2018Dec 31, 2018$15.05M-89.0%
2017Dec 29, 2017$136.39M+34.8%
2016Dec 30, 2016$101.18M–

More Summit Therapeutics figures

See a number that looks wrong?